Neupro 3 MG/24 HR patch 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F3TAW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,457
Award facts
- Contract value 100% obligated
- $11,457.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,457.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Neupro 3 mg/24 hour transdermal patches (30-count units). The contract, which is not set-aside and was competitively awarded, is scheduled for completion by January 8, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with this delivery order fulfilled from its place of performance in Conshohocken, PA. The company operates as a subsidiary of parent organization Cencora, Inc., which does business as AmerisourceBergen.
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive IDC provides global pharmaceutical support for military healthcare programs and enables the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Neupro, a rotigotine transdermal patch used for treating Parkinson's disease symptoms, represents the type of neurological medication within the company's extensive portfolio of federal medical product deliveries.
Quick answers
Who was awarded contract SPE2DR26F3TAW?
SPE2DR26F3TAW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F3TAW worth?
The government has obligated $11,457 on SPE2DR26F3TAW.
Is contract SPE2DR26F3TAW an order under another contract?
Yes. SPE2DR26F3TAW is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3TAW competed?
The extent of competition for SPE2DR26F3TAW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award